Largest-ever Ozempic and GLP-1 drug study finds they lower risk of 42 health conditions, including heart attacks and Alzheimer’s disease
The study included nearly 2 million patients, making it the largest ever conducted on this group of glucagon-like peptide-1 ...
Popular GLP-1 medications may have health benefits that extend beyond weight loss and blood sugar control, a new study finds
Popular GLP-1 medications approved for weight loss, diabetes, and heart disease may have untapped potential to reduce the ...
Hosted on MSN48m
Researchers create an atlas of health associations for GLP-1 receptor agonists
By Dr. Priyom Bose, Ph.D. Study of 2.4 million participants reveals potential advantages for cardiometabolic and psychiatric ...